| Value | ₹32.33 Cr |
|---|
BSE filing, NSE: GUJALKALI. Summary written from the filing by ALFA Finder's alert engine.
Gujarat Alkalies & Chemicals Ltd: key numbers
- Share price
- ₹540.05
- Market cap
- ₹3,966 Cr
- Revenue (annual)
- ₹4,358 Cr
- Net profit (annual)
- ₹-2.41 Cr
- P/E (TTM)
- 59.8×Sector 34.1×
- Promoter holding
- 47.28%+0.00% QoQ
- FII holding
- 3.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gujarat Alkalies & Chemicals Ltd
All →Gujarat Alkalies & Chemicals Business Update
Gujarat Alkalies reported that 6.6 MW of its 75.9 MW Clean Max hybrid power project is now operative. The project is in stabilisation, and the remaining supply will follow in due course.
- hybrid power capacity operative
- 6.6 MW
Gujarat Alkalies & Chemicals Board Meeting Date
GACL notified a board meeting on 5 November 2026 to consider Q2 and H1 FY27 provisional results. The trading window will remain closed until 7 November 2026.
Gujarat Alkalies & Chemicals Capacity Expansion
GACL conducted the ground-breaking ceremony of its 33,870 TPA food-grade phosphoric acid plant PPA-II at Dahej. The facility marks the start of construction for capacity expansion.
- phosphoric acid production capacity
- 33870 TPA
Gujarat Alkalies & Chemicals Other Announcement
Gujarat Alkalies and Chemicals Limited has published newspaper advertisements regarding a special window for the transfer and dematerialization of physical securities as per SEBI regulations.
Gujarat Alkalies & Chemicals Other Announcement
Gujarat Alkalies and Chemicals Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended 30 September 2026.
Gujarat Alkalies & Chemicals Annual General Meeting
Gujarat Alkalies and Chemicals Limited conducted its 53rd Annual General Meeting on September 25, 2026. Members considered dividend declaration and approval of material related party transactions.
Other acquisition announcements
All →Fidel Softech Acquisition Worth ₹3.84 Cr
Fidel Softech agreed to acquire 100% of Softenger (India) Pvt Ltd and Soft Data Middle Eastern IT Solutions LLC. Consideration is ₹3.84 Crore.
- Value
- ₹3.84 Cr
- Execution
- 31 December 2026
Krishna Institute of Medical Sciences Acquisition Worth ₹15 Cr
KIMS acquired a 5.82% stake in Ushahkal Abhinav Specialty Hospital LLP for Rs.15 Crore via primary infusion. The Sangli hospital reported FY26 turnover of Rs.80.42 Crore.
- Value
- ₹15.00 Cr
Krishna Institute of Medical Sciences Acquisition Worth ₹79.5 Cr
KIMS Ltd acquired a 51% stake in Sarvottam Health Care Private Limited for up to ₹79.50 Crore, aiming to expand its healthcare operations in Kakinada.
- Value
- ₹79.50 Cr
Meesho Acquisition Worth ₹50 Cr
Meesho approved up to Rs.50 Crore further investment in Retail Pulse Labs, payable in tranches. It follows the Kirana Club acquisition, making RPLPL a step-down subsidiary.
- Value
- ₹50.00 Cr
- Execution
- Within 1 year from the closing of the first tranche of the original acquisition
Meesho Acquisition Worth ₹18.74 Cr
Meesho will acquire a further stake in Retail Pulse Labs for ₹18.74 Crore cash. The step-down deal depends on completing the first Kirana Club tranche.
- Value
- ₹18.74 Cr
Meesho Acquisition Worth ₹6.17 Cr
Meesho will acquire 100% of Singapore-based Kirana Club in cash, up to USD 6.5 lakh in tranches. The target runs a digital platform for grocery retailers.
- Value
- ₹6.17 Cr